Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis

The clinical benefit and potential risks of conversion surgery after neoadjuvant chemotherapy (NACT) have not been fully investigated in patients with borderline resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAPC). Therefore, this has been evaluated in a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Changhoon, Shin, Sang Hyun, Kim, Kyu-pyo, Jeong, Jae Ho, Chang, Heung-Moon, Kang, Jun Ho, Lee, Sang Soo, Park, Do Hyun, Song, Tae Jun, Seo, Dong Wan, Lee, Sung Koo, Kim, Myung-Hwan, Park, Jin-hong, Hwang, Dae Wook, Song, Ki Byung, Lee, Jae Hoon, Ryoo, Baek-Yeol, Kim, Song Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468804/
https://www.ncbi.nlm.nih.gov/pubmed/30813624
http://dx.doi.org/10.3390/cancers11030278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468804/
https://www.ncbi.nlm.nih.gov/pubmed/30813624
http://dx.doi.org/10.3390/cancers11030278

Ejemplares similares